(Q37979650)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Imaging in prostate cancer staging: present role and future perspectives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Giuseppe Palermo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

7

Marco Racioppi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1

Francesco Pinto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Angelo Totaro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Alessandro Calarco

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Alessandro D'Addessi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

AnnaLia Valentini

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Benedetta Gui

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

PierFrancesco Bassi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

27 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

published in

Urologia Internationalis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

125-136

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

Estimates of cancer incidence and mortality in Europe in 2008.

21 January 2020

cites work

1 reference

Mortality reductions produced by sustained prostate cancer screening have been underestimated

21 January 2018

1 reference

21 January 2018

Cancer statistics, 1990.

1 reference

21 January 2018

Cancer statistics, 2005

1 reference

Focal therapy in prostate cancer: modalities, findings and future considerations.

21 January 2018

1 reference

Imaging localized prostate cancer: current approaches and new developments.

21 January 2018

1 reference

Prostate-specific antigen best practice policy--part II: prostate cancer staging and post-treatment follow-up

21 January 2018

1 reference

New horizons in prostate cancer imaging

21 January 2018

1 reference

Detection of microscopic extracapsular extension prior to radical prostatectomy for clinically localized prostate cancer

21 January 2018

1 reference

Imaging modalities for prostate cancer

21 January 2018

1 reference

Evolution of precise and multimodal MRI and TRUS in detection and management of early prostate cancer

21 January 2018

1 reference

Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.

21 January 2018

1 reference

Status of transrectal ultrasound imaging of the prostate.

21 January 2018

1 reference

21 January 2018

Imaging prostate cancer

1 reference

Transition zone prostate cancer: metabolic characteristics at 1H MR spectroscopic imaging--initial results

21 January 2018

1 reference

Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging

21 January 2018

1 reference

Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis

21 January 2018

1 reference

Extraprostatic spread of clinically localized prostate cancer: factors predictive of pT3 tumor and of positive endorectal MR imaging examination results

21 January 2018

1 reference

Endorectal magnetic resonance imaging of prostatic cancer: comparison between fat-suppressed T2-weighted fast spin echo and three-dimensional dual-echo, steady-state sequences.

21 January 2018

1 reference

Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging.

21 January 2018

1 reference

Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension.

21 January 2018

1 reference

Is endorectal coil necessary for the staging of clinically localized prostate cancer? Comparison of non-endorectal versus endorectal MR imaging.

21 January 2018

1 reference

Focal treatment or observation of prostate cancer: pretreatment accuracy of transrectal ultrasound biopsy and T2-weighted MRI.

21 January 2018

1 reference

Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms

21 January 2018

1 reference

Unnecessary imaging for the staging of low-risk prostate cancer is common

21 January 2018

1 reference

Mitochondrial function, zinc, and intermediary metabolism relationships in normal prostate and prostate cancer

21 January 2018

1 reference

Advances in MR spectroscopy of the prostate

21 January 2018

1 reference

Imaging in prostate cancer diagnosis: present role and future perspectives

21 January 2018

1 reference

Magnetic resonance spectroscopic imaging: current status in the management of prostate cancer.

21 January 2018

1 reference

MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer

21 January 2018

1 reference

Modern role of magnetic resonance and spectroscopy in the imaging of prostate cancer

21 January 2018

1 reference

Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging

21 January 2018

1 reference

Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy: experienced versus less experienced readers

21 January 2018

1 reference

MRI of prostate cancer at 1.5 and 3.0 T: comparison of image quality in tumor detection and staging.

21 January 2018

1 reference

Prostate cancer: body-array versus endorectal coil MR imaging at 3 T--comparison of image quality, localization, and staging performance.

21 January 2018

1 reference

Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging--initial results.

21 January 2018

1 reference

Functional magnetic resonance imaging in prostate cancer

21 January 2018

1 reference

The effects of the period between biopsy and diffusion-weighted magnetic resonance imaging on cancer staging in localized prostate cancer.

21 January 2018

1 reference

Diffusion-weighted MRI at 3 T for the evaluation of prostate cancer

21 January 2018

1 reference

Diffusion-weighted MR imaging for the evaluation of seminal vesicle invasion in prostate cancer: initial results.

21 January 2018

1 reference

Positron emission tomography provides molecular imaging of biological processes

21 January 2018

1 reference

Enzymology of cancer cells (second of two parts).

21 January 2018

1 reference

Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer

21 January 2018

1 reference

Imaging techniques for prostate cancer: implications for focal therapy

21 January 2018

1 reference

Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review

21 January 2018

1 reference

Dietary choline: biochemistry, physiology, and pharmacology

21 January 2018

1 reference

Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.

21 January 2018

1 reference

11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer

21 January 2018

1 reference

11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy.

21 January 2018

1 reference

18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients

21 January 2018

1 reference

Non-invasive molecular imaging of prostate cancer lymph node metastasis

21 January 2018

1 reference

The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis

21 January 2018

1 reference

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

21 January 2018

1 reference

New agents and techniques for imaging prostate cancer

21 January 2018

1 reference

11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms

21 January 2018

1 reference

[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: Preliminary results from a prospective histology-based study

21 January 2018

1 reference

[18F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study.

21 January 2018

1 reference

State-of-the-art approaches to detecting early bone metastasis in prostate cancer

21 January 2018

1 reference

Imaging metastatic bone disease from carcinoma of the prostate

21 January 2018

1 reference

Diagnostic and therapeutic use of radioisotopes for bony disease in prostate cancer: current practice.

21 January 2018

1 reference

Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies.

21 January 2018

1 reference

Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations

21 January 2018

1 reference

Usefulness of single photon emission computed tomography imaging in the detection of lumbar vertebral metastases from prostate cancer.

21 January 2018

1 reference

The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate

21 January 2018

1 reference

Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancer

21 January 2018

1 reference

Imaging of prostate cancer

21 January 2018

1 reference

Positron emission tomography for prostate, bladder, and renal cancer

21 January 2018

1 reference

Role of 11C-choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy.

21 January 2018

1 reference

¹⁸F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers.

21 January 2018

1 reference

¹⁸F-Fluoromethylcholine (FCH) PET imaging in patients with castration-resistant prostate cancer: prospective comparison with standard imaging.

21 January 2018

1 reference

Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000335205

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22286304%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference